U.S. market Closed. Opens in 11 hours 17 minutes

KTTA | Pasithea Therapeutics Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
RevenueN/A486.56K15.06KN/A
Cost of Revenue648.45K113.19K17.27KN/A
Gross Profit-648.45K373.36K-2.21KN/A
Operating Expenses15.33M15.19M4.51M40.98K
Selling, General & Admin7.23M12.52M4.51M40.98K
Research & Development8.10M2.67MN/AN/A
Other Operating ExpensesN/A44.72KN/AN/A
Operating Income-15.98M-14.82M-4.51M-40.98K
Other Expenses / Income471.61K879.87K2.33M-4.00
Before Tax Income-15.51M-13.94M-2.17M-40.98K
Income Tax Expenses453.91M-879.97K508.00-61.48K
Net Income-15.96M-13.06M-2.17M-40.98K
Interest ExpensesN/A102.00508.00N/A
Basic Shares Outstanding1.23M1.26M1.15M688.92K
Diluted Shares Outstanding1.23M1.26M1.15M688.92K
EBITDA-15.33M-14.74M-4.51M-40.98K
EBITDA Margin0.00%-3,029.28%-29,916.57%0.00%
EBIT437.95M-13.94M-2.17M-102.46K
EBIT Margin0.00%-2,864.27%-14,427.12%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙